Bio-Path Holdings (BPTH) has provided an announcement.
Bio-Path Holdings, Inc. has announced their participation in two major events where they will present data: the American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association Congress, both taking place in May 2024. These presentations are expected to offer valuable insights into the company’s research and advancements, potentially impacting their stock and investor interest.
See more insights into BPTH stock on TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
